In contrast, numerous studies have supported the utility of elevated CSF IL-10 in distinguishing PCNSL from other brain tumors, neuroinflammatory conditions, and systemic DLBCL (38–41). This evidence concerns the gene IL10 and diffuse large B-cell lymphoma.